-
1
-
-
33846781660
-
Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers
-
Hillaireau H et al 2007 Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers Int. J. Pharm. 331 148-52
-
(2007)
Int. J. Pharm.
, vol.331
, Issue.2
, pp. 148-152
-
-
Hillaireau, H.1
Al, E.2
-
2
-
-
34748880897
-
PEGylated bioactive molecules in biodegradable polymer microparticles
-
Schmidt P G et al 2007 PEGylated bioactive molecules in biodegradable polymer microparticles Expert Opin. Biol. Ther. 7 1427-36
-
(2007)
Expert Opin. Biol. Ther.
, vol.7
, Issue.9
, pp. 1427-1436
-
-
Schmidt, P.G.1
Al, E.2
-
3
-
-
37549058856
-
Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
-
Lindvall O and Wahlberg L U 2008 Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Exp. Neurol. 209 82-8
-
(2008)
Exp. Neurol.
, vol.209
, Issue.1
, pp. 82-88
-
-
Lindvall, O.1
Wahlberg, L.U.2
-
4
-
-
36649033827
-
In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules
-
Murua A et al 2007 In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules Biomacromolecules 8 3302-7
-
(2007)
Biomacromolecules
, vol.8
, Issue.11
, pp. 3302-3307
-
-
Murua, A.1
Al, E.2
-
5
-
-
0036378210
-
Delivery of erythropoitin by encapsulated myoblasts in a genetic model of severe anemia
-
Rinsch C et al 2002 Delivery of erythropoitin by encapsulated myoblasts in a genetic model of severe anemia Kidney Int. 62 1395-401
-
(2002)
Kidney Int.
, vol.62
, Issue.4
, pp. 1395-1401
-
-
Rinsch, C.1
Al, E.2
-
6
-
-
0035030502
-
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia
-
Rinsch C et al 2001 Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia Gene Therapy 8 523-33
-
(2001)
Gene Therapy
, vol.8
, Issue.7
, pp. 523-533
-
-
Rinsch, C.1
Al, E.2
-
7
-
-
0034662015
-
Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression
-
Peduto G et al 2000 Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression Transplantation 70 78-85
-
(2000)
Transplantation
, vol.70
, pp. 78-85
-
-
Peduto, G.1
Al, E.2
-
8
-
-
0035865457
-
Inducing host acceptance to encapsulated xenogeneic myoblasts
-
Rinsch C et al 2001 Inducing host acceptance to encapsulated xenogeneic myoblasts Transplantation 71 345-51
-
(2001)
Transplantation
, vol.71
, Issue.3
, pp. 345-351
-
-
Rinsch, C.1
Al, E.2
-
9
-
-
0028049694
-
Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain
-
Joseph J M et al 1994 Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain Cell Transplant. 3 355-64
-
(1994)
Cell Transplant.
, vol.3
, pp. 355-364
-
-
Joseph, J.M.1
Al, E.2
-
10
-
-
0027288001
-
Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances
-
Sagen J et al 1993 Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances J. Neurosci. 13 2415-23
-
(1993)
J. Neurosci.
, vol.13
, pp. 2415-2423
-
-
Sagen, J.1
Al, E.2
-
11
-
-
0033771207
-
Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells
-
Zurn A D et al 2000 Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells Cell Transplant. 9 471-84
-
(2000)
Cell Transplant.
, vol.9
, pp. 471-484
-
-
Zurn, A.D.1
Al, E.2
-
12
-
-
10644233978
-
In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings
-
Norton L W et al 2005 In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings Biomaterials 26 3285-97
-
(2005)
Biomaterials
, vol.26
, Issue.16
, pp. 3285-3297
-
-
Norton, L.W.1
Al, E.2
-
13
-
-
4544340443
-
Cellulose acetate hollow fiber membranes blended with phospholipid polymer and their performance for hemopurification
-
Ye S H, Watanabe J and Ishihara K 2004 Cellulose acetate hollow fiber membranes blended with phospholipid polymer and their performance for hemopurification J. Biomater. Sci. Polym. Ed. 15 981-1001
-
(2004)
J. Biomater. Sci. Polym. Ed.
, vol.15
, Issue.8
, pp. 981-1001
-
-
Ye, S.H.1
Watanabe, J.2
Ishihara, K.3
-
14
-
-
14844283729
-
Biocompatibility and stability of disulfide-crosslinked hyaluronan films
-
Liu Y, Shu X Z and Prestwich G D 2005 Biocompatibility and stability of disulfide-crosslinked hyaluronan films Biomaterials 26 4737-46
-
(2005)
Biomaterials
, vol.26
, Issue.23
, pp. 4737-4746
-
-
Liu, Y.1
Shu, X.Z.2
Prestwich, G.D.3
-
15
-
-
33646886616
-
Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: Mechanical properties and corneal epithelial cell interactions
-
Duan X and Sheardown H 2006 Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions Biomaterials 27 4608-17
-
(2006)
Biomaterials
, vol.27
, Issue.26
, pp. 4608-4617
-
-
Duan, X.1
Sheardown, H.2
-
16
-
-
5044241166
-
Influence of weak and covalent bonds on formation and hydrolysis of gelatin networks
-
Giraudier S et al 2004 Influence of weak and covalent bonds on formation and hydrolysis of gelatin networks Biomacromolecules 5 1662-6
-
(2004)
Biomacromolecules
, vol.5
, Issue.5
, pp. 1662-1666
-
-
Giraudier, S.1
Al, E.2
-
18
-
-
33750078388
-
Synthetic nerve guide implants in humans: A comprehensive survey
-
Schlosshauer B et al 2006 Synthetic nerve guide implants in humans: a comprehensive survey Neurosurgery 59 740-7 discussion 747-8
-
(2006)
Neurosurgery
, vol.59
, Issue.4
, pp. 740-747
-
-
Schlosshauer, B.1
Al, E.2
-
19
-
-
30944457288
-
Physical and biological performance of a novel block copolymer nerve guide
-
Lietz M et al 2006 Physical and biological performance of a novel block copolymer nerve guide J. Biotech. Bioeng. 5 99-109
-
(2006)
J. Biotech. Bioeng.
, vol.93
, Issue.1
, pp. 99-109
-
-
Lietz, M.1
Al, E.2
-
20
-
-
0036010289
-
Development of a bioartificial nerve graft I. Design based on a reaction-diffusion model
-
Rutkowski G E and Heath C A 2002 Development of a bioartificial nerve graft I. Design based on a reaction-diffusion model Biotechnol. Prog. 18 362-72
-
(2002)
Biotechnol. Prog.
, vol.18
, Issue.2
, pp. 362-372
-
-
Rutkowski, G.E.1
Heath, C.A.2
-
21
-
-
33748336919
-
Scarring impedes regeneration at sites of peripheral nerve repair
-
Atkins S et al 2006 Scarring impedes regeneration at sites of peripheral nerve repair Neuroreport 17 1245-9
-
(2006)
Neuroreport
, vol.17
, Issue.12
, pp. 1245-1249
-
-
Atkins, S.1
Al, E.2
-
22
-
-
0347628883
-
Effects of hyaluronic acid on peripheral nerve scarring and regeneration in rats
-
Ozgenel G Y 2003 Effects of hyaluronic acid on peripheral nerve scarring and regeneration in rats Microsurgery 23 575-81
-
(2003)
Microsurgery
, vol.23
, Issue.6
, pp. 575-581
-
-
Ozgenel, G.Y.1
-
23
-
-
16244396148
-
Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier
-
Steuer H et al 2005 Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier Invest. Ophthalmol. Vis. Sci. 46 1047-53
-
(2005)
Invest. Ophthalmol. Vis. Sci.
, vol.46
, Issue.3
, pp. 1047-1053
-
-
Steuer, H.1
Al, E.2
-
24
-
-
1942455881
-
In vitro model of the outer blood-retina barrier
-
Steuer H et al 2004 In vitro model of the outer blood-retina barrier Brain Res. Brain Res. Protoc. 13 26-36
-
(2004)
Brain Res. Brain Res. Protoc.
, vol.13
, Issue.1
, pp. 26-36
-
-
Steuer, H.1
Al, E.2
-
25
-
-
0029060204
-
Axonal guidance in the chicken retina
-
Stier H and Schlosshauer B 1995 Axonal guidance in the chicken retina Development 121 1443-54
-
(1995)
Development
, vol.121
, pp. 1443-1454
-
-
Stier, H.1
Schlosshauer, B.2
-
26
-
-
38349039417
-
Mineralised collagen-an artificial, extracellular bone matrix-improves osteogenic differentiation of bone marrow stromal cells
-
Bernhardt A, Lode A, Boxberger S, Pompe W and Gelinsky M 2007 Mineralised collagen-an artificial, extracellular bone matrix-improves osteogenic differentiation of bone marrow stromal cells J. Mater. Sci. Mater. Med. 19 269-75
-
(2007)
J. Mater. Sci. Mater. Med.
, vol.19
, Issue.1
, pp. 269-275
-
-
Bernhardt, A.1
Lode, A.2
Boxberger, S.3
Pompe, W.4
Gelinsky, M.5
-
27
-
-
21444452410
-
Renal epithelia in long term gradient culture for biomaterial testing and tissue engineering
-
Minuth W W, Schumacher K and Strehl R 2005 Renal epithelia in long term gradient culture for biomaterial testing and tissue engineering Biomed. Mater. Eng. 15 51-63
-
(2005)
Biomed. Mater. Eng.
, vol.15
, pp. 51-63
-
-
Minuth, W.W.1
Schumacher, K.2
Strehl, R.3
-
28
-
-
33750029375
-
Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles
-
Bitterle E et al 2006 Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles Chemosphere 65 1784-90
-
(2006)
Chemosphere
, vol.65
, Issue.10
, pp. 1784-1790
-
-
Bitterle, E.1
Al, E.2
-
29
-
-
34047161596
-
Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea
-
Tan Q et al 2007 Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea Eur. J. Cardiothorac. Surg. 31 806-11
-
(2007)
Eur. J. Cardiothorac. Surg.
, vol.31
, Issue.5
, pp. 806-811
-
-
Tan, Q.1
Al, E.2
-
30
-
-
34249092703
-
Technical and theoretical considerations about gradient perfusion culture for epithelia used in tissue engineering, biomaterial testing and pharmaceutical research
-
Minuth W W and Strehl R 2007 Technical and theoretical considerations about gradient perfusion culture for epithelia used in tissue engineering, biomaterial testing and pharmaceutical research Biomed. Mater. 2 R1-11
-
(2007)
Biomed. Mater.
, vol.2
, Issue.2
, pp. 1-11
-
-
Minuth, W.W.1
Strehl, R.2
-
31
-
-
35348855017
-
Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells
-
Kim I Y et al 2007 Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells J. Biochem. Mol. Biol. 40 825-31
-
(2007)
J. Biochem. Mol. Biol.
, vol.40
, pp. 825-831
-
-
Kim, I.Y.1
Al, E.2
-
32
-
-
34247550164
-
Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: Implications for development and arthritis
-
Tchetina E V et al 2007 Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis Matrix Biol. 26 247-58
-
(2007)
Matrix Biol.
, vol.26
, Issue.4
, pp. 247-258
-
-
Tchetina, E.V.1
Al, E.2
-
33
-
-
34547173586
-
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes
-
Gabriel D et al 2007 Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes Bioconjug. Chem. 18 1070-7
-
(2007)
Bioconjug. Chem.
, vol.18
, Issue.4
, pp. 1070-1077
-
-
Gabriel, D.1
Al, E.2
-
34
-
-
15344344686
-
Latent cytokines: Development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3
-
Vessillier S, Adams G and Chernajovsky Y 2004 Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3 Protein Eng. Des. Sel. 17 829-35
-
(2004)
Protein Eng. Des. Sel.
, vol.17
, Issue.12
, pp. 829-835
-
-
Vessillier, S.1
Adams, G.2
Chernajovsky, Y.3
-
35
-
-
19644367664
-
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
-
Lutolf M P and Hubbell J A 2005 Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat. Biotechnol. 23 47-55
-
(2005)
Nat. Biotechnol.
, vol.23
, Issue.1
, pp. 47-55
-
-
Lutolf, M.P.1
Hubbell, J.A.2
-
36
-
-
34447634505
-
Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
-
Buss A et al 2007 Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury BMC Neurol. 7 17
-
(2007)
BMC Neurol.
, vol.7
, Issue.1
, pp. 17
-
-
Buss, A.1
Al, E.2
-
37
-
-
52649096753
-
TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease
-
Li Y et al 2006 TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease J. Huazhong Univ. Sci. Technol. Med. Sci. 26 647-50
-
(2006)
J. Huazhong Univ. Sci. Technol. Med. Sci.
, vol.26
, Issue.6
, pp. 647-650
-
-
Li, Y.1
Al, E.2
-
38
-
-
36849020581
-
Development of musculoskeletal toxicity without clear benefit after administration of PG 116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: A randomized, 12 month, double-blind, placebo-controlled study
-
Krzeski P et al 2007 Development of musculoskeletal toxicity without clear benefit after administration of PG 116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12 month, double-blind, placebo-controlled study Arthritis Res. Ther. 9 R109
-
(2007)
Arthritis Res. Ther.
, vol.9
, Issue.5
, pp. 109
-
-
Krzeski, P.1
Al, E.2
|